Cetraria Islandica Subsp. Islandica
- Plant preparation
- Varies by country
- Identity checked
- Sources last checked 2026-09-04
This page shows what was measured, who it was measured in, and what that does not settle.
What Cetraria Islandica Subsp. Islandica does in the body
Symptoms associated with laryngitis and voice hoarseness
What happened in people
RNAWiki has not yet published a reviewed conclusion for this use.
A fixed RNAWiki sentence
Where this came from
Wording RNAWiki always uses, not a finding about this substance.
No reviewed claim names a result for any goal on this record.
No source is stored against this line.
The limit that matters most
Not recorded.
- Where it acts
- Not recorded.
- Kind of result
- No result is published, so no kind of result applies yet
- Supervision
- Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.
What the registries record it as
The substance registry classes this as structurallydiverse.
FDA substance registry · BJ7YPN79A1 · read 2026-08-29
The material is recorded as coming from fungus.
FDA substance registry · BJ7YPN79A1 · read 2026-08-29
The organism is Cetraria islandica subsp. islandica, a subspecies.
NCBI Taxonomy · 95628 · read 2026-08-29
Where each sentence above came from
No plain explanation of what this changes is stored. The page opens with what it is taken for instead, and the recorded explanation follows below.
Shown as the opening line on this page.
No statement of the main limit is recorded.
The four opening statements run to 22 words.
Words this page uses
Four words worth knowing first
Chosen from what this page shows, with each one explained before the word it depends on.
Biomarker
A biomarker is a number from a test that stands in for something about health.
A picture of it, and where the picture fails
A biomarker is like a fuel gauge.
Where that stops being true. A gauge is wired to the tank. Many biomarkers are only loosely tied to health.
What people get wrong. A better number is read as a better life. Several medicines improved a number and helped nobody.
A measurable indicator used as a substitute for a clinical outcome of interest.
Placebo
A placebo is a dummy treatment given so the real one can be compared with it.
A picture of it, and where the picture fails
A placebo is like a blank control in an experiment.
Where that stops being true. A blank does nothing. People given a placebo often do get better.
What people get wrong. A placebo effect is read as imaginary. The improvement is measured and real.
An inactive intervention matched in appearance to the test intervention, used to control for non-specific effects.
Comparator
A comparator is whatever the treatment was measured against.
A picture of it, and where the picture fails
It is like the other runner in a race.
Where that stops being true. A race has one winner. A study can show both arms improved.
What people get wrong. Results are read without asking what the other group got. Beating nothing is not beating a treatment.
The control condition against which the experimental intervention is assessed.
What is missing or unclearRead from sources, not yet reviewed
Were people like you studied?
RNAWiki cannot tell whether a study fits you. It can show who was in it, and where the result stops carrying.
Who was studied
People similar to this profile were included.
- For the temporary relief of symptoms associated with mild skin irritation. Directions Adults and adolescents (12 years and older): Take 5 drops three times daily or as recommended by your healthcare practitioner. Children (under 12 years): Take under the direction of your healthcare practitioner.
Who is missing from the studies
- Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
Where the result stopped carrying
- This is a scope explorer, not a diagnosis engine.
- It shows who was studied so you can see whether people similar to you were included.
RNAWiki cannot tell whether a study fits you. It can show who was in it.
What it would be like to takeRead from sources, not yet reviewed
Why it might seem to do nothing
A real effect and a noticed effect are different things. These are the recorded reasons the two come apart.
The people in the studies were not much like the reader.
On this record: Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
Small early studies often do not hold up.
On this record: RNAWiki has not yet published a reviewed conclusion for this use.
Other reasons RNAWiki checked and found nothing for (11)
- It was studied for a different goal
- The studies measured something else entirely. Nothing in this record points to this reason.
- A different form was studied
- The studied form is not the form on the shelf. Nothing in this record points to this reason.
- There was nothing to correct
- Where a level is already normal, topping it up may change nothing. Nothing in this record points to this reason.
- Something else had to happen too
- In the studies it was paired with training, a diet or another treatment. Nothing in this record points to this reason.
- The change is too small to feel
- A real change can still sit below what a person notices. Nothing in this record points to this reason.
- Day-to-day swing hides it
- Sleep, food, stress and time of day move most numbers more than this would. Nothing in this record points to this reason.
- Not enough time yet
- The studies ran longer than the person has waited. Nothing in this record points to this reason.
- It was not taken as studied
- Missed days change the result, and studies count them. Nothing in this record points to this reason.
- Something else changed at the same time
- Two changes at once cannot be told apart afterwards. Nothing in this record points to this reason.
- The product may not be what it says
- Contents of a sold product are not always what the label states. Nothing in this record points to this reason.
- No recorded reason
- RNAWiki has nothing stored that would explain it. Nothing in this record points to this reason.
None of these is a reason to take more. Taking more is not a step this page ever suggests.
What it would be like to takeRead from sources, not yet reviewed
What taking it involves
The recorded facts about getting hold of it and using it. Nothing here is a suggestion about what you should do.
How it is supplied
Varies by country
Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
Read from the recorded approval status.
No source is stored against this line.
Form and route
Oral
Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form and route recorded on this substance.
No source is stored against this line.
Who oversees it
Not usually supervised: sold as a supplement or food ingredient where recorded. That is a legal category, not a safety judgement.
Quoted from a source
Where this came from
Copied from a source RNAWiki stored, with the source named.
The identity record classes it as a botanical or organism preparation; no register records an approval.
No source is stored against this line.
What is in the pack
Sold as liquid, solution/ drops, given by the oral route.
Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
Recorded notes on how this is sold and what that means for what is in the pack.
No source is stored against this line.
Where it is registered
Regulatory records are listed in the technical disclosure at the foot of this page.
Counted from records
Where this came from
A count of rows RNAWiki holds. It describes our records, not your body.
Register entries are stored per jurisdiction and shown with their dates.
No source is stored against this line.
Why people stop
Not recorded.
Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
No record of why people stopped taking it is stored for this substance.
No source is stored against this line.
What it would be like to takeNothing found in the sources checked
What can go wrong
Sorted by where each line came from. A regulator's label and a report somebody sent in are not the same kind of fact.
Nothing found in the sources checked
No harm is recorded against this substance in the sources RNAWiki checked. Finding nothing is not the same as showing there is nothing.
The sources listed were searched and held nothing. That is not the same as nothing existing.
Over a long time. No completed tested study window is recorded, so long-term effects are not established by the registry record.
Groups the studies covered thinly. Which groups were under-represented in the studies has not been recorded for this substance. Pregnancy, breastfeeding, children, older adults, and people with liver or kidney conditions are commonly excluded from trials; nothing here says whether they were.
What is missing or unclearRead from sources, not yet reviewed
Does the exact form matter?
Evidence belongs to the exact thing that was tested. A different salt, a different mixture or a different preparation is a different question.
The form that was studied
Oral
Source-linked record
Where this came from
A person wrote this into the record with the study named beside it. No reviewer has signed it off.
The form used in the studies cited on this page.
No source is stored against this line.
What is sold
Not recorded.
Nothing recorded
Where this came from
RNAWiki holds nothing here and says so rather than guessing.
Nothing further is recorded about which forms are sold.
No source is stored against this line.
What is recorded as being sold
19 products list this as an active ingredient in the United States drug directory. None of them contains it on its own, so nothing on this page can separate it from what it is combined with.
FDA National Drug Code directory · 63388-915 · read 2026-08-29
They are sold as liquid and solution/ drops, taken oral.
FDA National Drug Code directory · 63388-915 · read 2026-08-29
18 published labels name it as an active ingredient. None of them describes this substance alone, so no label text on this page can be attributed to it rather than to a combination.
US prescribing information · caf462e7-73a9-4954-b33b-81573fb0c3a6 · read 2026-08-29
Those labels are classed as human otc drug.
US prescribing information · caf462e7-73a9-4954-b33b-81573fb0c3a6 · read 2026-08-29
33 marketed supplement labels list this ingredient, classed as botanical, non-nutrient/non-botanical and other combinations.
NIH Dietary Supplement Label Database · 233889 · read 2026-08-29
Those labels carry all other, nutrient and structure/function claims. A claim of that kind is written by the manufacturer and is not assessed by any regulator, so its presence says nothing about whether it is true.
NIH Dietary Supplement Label Database · 233889 · read 2026-08-29
Evidence carries across two names for one substance. It does not carry across a salt, a mirror form or a mixture.
What it would be like to takeRead from sources, not yet reviewed
What you could measure
Watching one thing carefully can tell you whether it moved. It cannot tell you what moved it.
This is sold without a prescription, so a person can sensibly watch one thing and see whether it moves.
Pick one goal. One goal only. Two at once cannot be told apart afterwards.
Pick one thing to watch. No registered study lists a measure RNAWiki could read for this.
Measure before you start. Take the same measurement several times first. One reading is not a starting point.
Know the swing. Write down how much it moves on its own across a normal week.
Change one thing. Change nothing else at the same time, including training and sleep.
Give it the study length. No finished study window is recorded, so no length is suggested here.
Track whether you took it. Missed days are the most common reason a home test shows nothing.
Read the trend. Look at the line across weeks. A single reading tells you almost nothing.
What not to measure
- Anything that swings more day to day than the change you are looking for.
- A wearable estimate of sleep stages, which is an estimate and not a measurement.
- Weight on one morning, which mostly records water.
- A feeling you did not write down before starting.
When to stop
- Stop if something new and unpleasant starts, and ask a pharmacist or doctor.
- Stop if you cannot keep everything else steady, because the result will not mean anything.
- Stop at the end of the window you set, and read the trend then.
Tracking can show whether something changed for you. It cannot show what caused it.
RNAWiki does not work out an amount for anyone.
What is missing or unclearRead from sources, not yet reviewed
What nobody knows yet
Open questions, each with why it is open and what would close it.
How much did people take in the studies?
The sources RNAWiki checked hold nothing for this field.
Why it matters. A result belongs to an amount. Without the amount the result floats free.
What would answer it
A stored source that records it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing populations
Which groups were under-represented in the studies has not been recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing long-term data
No completed tested study window is recorded.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
No reviewed conclusion
RNAWiki has not yet published a reviewed conclusion for this use.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Missing interaction studies
No interaction was found in the registers checked. Not finding one is not the same as showing there is none.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Formulation uncertainty
Several salts, forms or products of Cetraria Islandica Subsp. Islandica are recorded. Results from one form may not transfer to another.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
Mechanism not reviewed
No reviewed mechanism story exists for this substance.
Why it matters. Recorded by the evidence model as a gap on this record.
What would answer it
A study that measures it, and a reviewer to sign it off.
Last checked 2026-09-04. Searched: The sources listed in the receipts at the foot of this page.
What happened in peopleRead from sources, not yet reviewed
Check any of this yourself
Every line above traced back to the study it came from. This is the technical layer, and the vocabulary changes here.
Where else this substance is registered
- FDA substance identifier (UNII)
- BJ7YPN79A1
- CAS registry number
- 84776-25-0
- RxNorm concept
- 1306351
- EMA substance identifier
- 100000134938
- European Chemicals Agency number
- 283-950-0
Checks this page had to pass
Passed
Identity resolved
no open identity hold
Passed
No unresolved merge across substance families
no quarantine open
Passed
Every public sentence names a source
The opening statement carries the origin: Written into the record, not signed off.
Not passed
Trial roles classified for highlighted evidence
No registered study is classified as testing this substance.
Passed
No internal keys in reader text
enforced by the copy-contract test over the rendered page
Passed
Safety mode resolved
The identity record classes it as a botanical or organism preparation; no register records an approval.
Passed
Canonical metadata present
slug and display name present
What is missing or unclearRead from sources, not yet reviewed
How this medicine reached us
Kept near the foot of the page. A historical event moves up only when it changes something about this substance today.
What the approval register records
The earliest marketing start date recorded for a listed product is 20100527.
FDA National Drug Code directory · 63388-915 · read 2026-08-29
What is missing or unclearRead from sources, not yet reviewed
What to learn next
Ordered by what would most change how you read this page, starting with what is easiest to misunderstand.
- Were people like me actually studied?
- How close is this evidence to something I would notice?
- What does nobody know about this yet?
- What is a biomarker?
This order is fixed in code and does not count clicks or time on the page.
What is not here
10 questions this page could not answer
These sections were prepared and left out because there was nothing to put in them. They are listed rather than hidden, so the gaps in this record are visible.
- What was measured, goal by goal — found nothing in the sources checked.
- What happened in people — found nothing in the sources checked.
- How close this is to real life — found nothing in the sources checked.
- The path through the body — found nothing in the sources checked.
- Felt, measured, or meaningful — found nothing in the sources checked.
- How long anything takes — found nothing in the sources checked.
- What it may clash with — found nothing in the sources checked.
- Other ways to the same goal — found nothing in the sources checked.
- Claims that go past the evidence — found nothing in the sources checked.
- What changed on this page — found nothing in the sources checked.
The record as stored
The full record, for auditing
Everything above is built from what is below. This layer keeps the technical vocabulary, record identifiers and every stored row, so a reader who wants to check the page can.
Recorded evidence blocks (5)
594 registered trials of Cetraria Islandica Subsp. Islandica — at which phases?
- Registered studies posting no result
- 427 of 594
594 registered studies of Cetraria Islandica Subsp. Islandica: 295 phase2, 156 phase1, 114 phase3, 50 na, 30 na or unstated, 11 early phase1, 2 phase4. CLINICALTRIALS_SNAPSHOT · 2026-09-01
0 with a PubMed record
Show the evidence
- phase2295
- phase1156
- phase3114
- na50
- na or unstated30
- early phase111
10 more recorded rows
- phase42
- completed216
- active not recruiting95
- recruiting94
- terminated76
- unknown54
- withdrawn30
- not yet recruiting26
- suspended2
- enrolling by invitation1
recorded 2026-09-01 · last checked 2026-09-04
104 of Cetraria Islandica Subsp. Islandica's trials stopped: safety, accrual/recruitment, funding/business, sponsor decision unspecified, other?
safety (6), accrual/recruitment (41), funding/business (6), sponsor decision unspecified (2) and other (49): Cetraria Islandica Subsp. Islandica's stop wording, clustered. CLINICALTRIALS_SNAPSHOT · 2026-09-01
"poor accrual"; 104 of 594 registered studies
Show the evidence
Trial
- NCT00002961terminated; "poor accrual"
- NCT00031590terminated; "The study was terminated prematurely due to slow accrual."
- NCT00124917terminated; "Study closed due to unanticipated toxicity/risks to subjects."
- NCT00176241terminated; "Slow accrual"
- NCT00176787terminated; "recruitment goals met"
- NCT00216008terminated; "IRB Closure"
14 further recorded trials
- NCT00256308terminated; "Halted prematurely due to slow accrual"
- NCT00352118terminated; "Low dose radiation treatment was not appropriate for these patients."
- NCT00353457terminated; "new studies were finding that Erbitux was not beneficial"
- NCT00354172terminated; "Competing study was started."
- NCT00376805terminated; "Withdrawn due to toxicity"
- NCT00378404terminated; "Slow accrual"
- NCT00447421terminated; "Interim results of another trial showed inferior activity of treatment"
- NCT00463840terminated; "Due to slow accrual"
- NCT00611858terminated; "Slow accrual"
- NCT00707473terminated; "\<75% participation"
- NCT00745134terminated; "The trial was stopped early because there was only one patient with pCR among the first 15 patients randomized to the curcumin arm."
- NCT00745732terminated; "Sponsor withdrew support."
- NCT00805597terminated; "The recuiting was to slow to complete the study"
- NCT00934518withdrawn; "Inadequate patient accrual"
recorded 2026-09-01 · last checked 2026-09-04
Which running trial of Cetraria Islandica Subsp. Islandica could settle lifespan?
NCT06612671 measures Overall survival, reading out 2025-09-30.
90 open trials; n 150; "Treatment Outcomes of Retroperitoneal Sarcoma"
Show the evidence
Trial
- NCT06612671"Treatment Outcomes of Retroperitoneal Sarcoma"; n 150; "Overall survival"; 2025-09-30
- NCT02887040"Study of Antineoplaston Therapy + Radiation vs. Radiation Only in Diffuse, Intrinsic, Brainstem Glioma"; n 92; "Change in Percentage of Participants Who Survived (Overall Survival)"; 2026-06
- NCT03410615"Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC"; n 129; "3 year event-free survival"; 2026-07-31
- NCT02101853"Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia"; n 669; "Disease Free Survival (DFS) of High-risk (HR) and Intermediate-risk (IR) Relapse Patients"; 2026-09-16
- NCT02112916"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma"; n 847; "Event-free Survival (EFS) for Modified Augmented Berlin-Frankfurt-Munster Backbone With or Without Bortezomib in All Randomized Patients"; 2026-09-16
- NCT03581292"Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations"; n 38; "Event Free Survival (EFS)"; 2026-10-16
14 further recorded trials
- NCT02567435"Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma"; n 325; "Event-free Survival (EFS)"; 2026-10-27
- NCT06391190"Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer"; n 20; "progression disease free survival"; 2026-12-30
- NCT03161522"Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer"; n 100; "Overall survival (OS)"; 2026-12-31
- NCT03712605"Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial"; n 280; "Recurrence free survival (RFS)"; 2026-12-31
- NCT03822897"De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma"; n 103; "Event-free Survival"; 2026-12-31
- NCT04623931"Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas"; n 40; "Progression free survival (PFS)"; 2026-12-31
- NCT04759586"Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma"; n 244; "Progression-free survival (PFS)"; 2026-12-31
- NCT03186898"Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer"; n 115; "Overall survival (OS)"; 2027-02-04
- NCT03907488"Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma"; n 994; "Progression Free Survival (PFS)"; 2027-03-28
- NCT03391869"Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer"; n 339; "Overall survival (OS) in overall population"; 2027-03-31
- NCT04230759"Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group"; n 180; "Disease-free survival (DFS)"; 2027-03-31
- NCT03410043"Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study"; n 173; "Progression free survival (PFS)"; 2027-04-01
- NCT04402788"Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial"; n 138; "Progression-free survival (PFS) (Phase II)"; 2027-04-30
- NCT06851247"GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma."; n 47; "2-year progression-free survival"; 2027-06
Which 105 trials of Cetraria Islandica Subsp. Islandica posted no result?
- Posted no result
- 105 of 105 completed trials
- Registrations
- NCT00023686, NCT00256789, NCT00256815, NCT00252798, NCT00033605 and NCT00215956, and 99 more
- Completion dates
- oldest 2004-04; newest 2024-07-09
Show the evidence
Trial
- NCT000236862004-04
- NCT002567892004-12
- NCT002568152005-09
- NCT002527982005-10
- NCT000336052006-07
- NCT002159562008-01
14 further recorded trials
- NCT001416482008-02
- NCT000059452008-06
- NCT000959272008-06
- NCT002304512008-07
- NCT005733652008-08
- NCT001974442008-12
- NCT001654772009-07
- NCT007189132009-09
- NCT002275652009-10
- NCT002879112009-12
- NCT010972522009-12
- NCT003304992010-02
- NCT005200912010-09
- NCT001457692011-05
At the median, Cetraria Islandica Subsp. Islandica's trials enrolled 43 people — anything larger?
- Median enrolment
- 43
- Largest enrolment
- 10273
- Registered trials counted
- 593
Where it is registered
Identifiers, relations and other names
The exact record
- UNII
- BJ7YPN79A1
- CAS number
- 84776-25-0
- RxCUI
- 1306351
- Trade name
- Real Relief, Kids Relief, Tox-Chord, Metal-Chord, Unda 27, Bacteria Chord, Real Relief / Kids Relief / Tox-Chord / Metal-Chord / Unda 27 / Bacteria Chord, Radiation, Chavita 4, Bronchitis Drops 2170, Radiation / Chavita 4 / Bronchitis Drops 2170 / Bacteria-Chord
- Also called
- Cetraria Islandica Whole, Iceland Moss, CETRARIA ISLANDICA, CETRARIA ISLANDICA EXTRACT, CETRARIA ISLANDICA SUBSP. ISLANDICA EXTRACT, CETRARIA ISLANDICA SUBSP. ISLANDICA WHOLE, CETRARIA ISLANDICA [HPUS], CETRARIA PLATYNA, Cetraria islandica [WHO-DD], Cetraria islandica extract [WHO-DD]
- Development code
- B2346 [LANGUAL]
Sources (2)
Sources
- CLINICALTRIALS_SNAPSHOT K1:BJ7YPN79A1 ·
- Drugs@FDA K1:BJ7YPN79A1 ·
ClinicalTrials.gov — US Government work · mixed register set; per-register licences in docs/specs/corpus-20k-sources.md
How these records are assembled · Which registers were checked
Index-quality checks
- identity passed: no open identity hold
- required summary fields resolved: 4 required field(s) not terminal: Why people use it, Best-supported result, Biggest unanswered question, Human evidence
- public claims reviewed: 0 reviewed claim(s); drafts are never rendered
- source coverage passed: 2 source rows
- no critical contamination: no quarantine open
- canonical metadata passed: slug and display name present
- no raw internal fields: enforced by the copy-contract test over the rendered page
This is a record of evidence. It is not medical advice, and it does not say this substance suits you. Nothing here says any substance on RNAWiki is appropriate for a child.